VAERS reports by lot

GSK Varicella/Shingles lot 957J3: VAERS reports

76 VAERS reports list lot 957J3 as a GSK Varicella/Shingles vaccine, received between 2018-07-06 and 2021-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
76
Reports
5%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8227%
Injection-site / Local reaction7625%
Neurological3512%
Dermatological (non-injection-site)3211%
Musculoskeletal238%
Gastrointestinal186%
Allergic / Anaphylactic155%
Cardiac / Cardiovascular93%
Respiratory41%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated10%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas14
Pennsylvania6
North Carolina6
California5
Oregon4
Rhode Island4
Virginia3
Oklahoma3
Colorado2
Washington2
Maryland2
Ohio2

Reports by month received

2018-076
2018-0836
2018-0915
2018-105
2018-115
2018-121
2019-011
2019-022
2019-091
2019-101
2019-111
2020-101
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.